Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ERBB3 anticorps (pTyr1222)

L’anticorps Lapin Monoclonal anti-ERBB3 a été validé pour WB et IHC (p). Il convient pour détecter ERBB3 dans des échantillons de Humain.
N° du produit ABIN6989639

Aperçu rapide pour ERBB3 anticorps (pTyr1222) (ABIN6989639)

Antigène

Voir toutes ERBB3 Anticorps
ERBB3 (Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3))

Reactivité

  • 161
  • 98
  • 83
  • 17
  • 6
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 165
  • 31
  • 1
  • 1
Lapin

Clonalité

  • 157
  • 41
Monoclonal

Conjugué

  • 106
  • 16
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
Cet anticorp ERBB3 est non-conjugé

Application

  • 99
  • 66
  • 53
  • 53
  • 52
  • 26
  • 25
  • 23
  • 21
  • 16
  • 11
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone

5F9
  • Épitope

    • 26
    • 25
    • 15
    • 15
    • 14
    • 9
    • 8
    • 7
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pTyr1222

     Réactivité croisée

    Humain

    Purification

    Purified by Protein A.

    Immunogène

    Synthetic phosphoPeptide corresponding to a region surrounding Tyrosine 1222 of Human ErbB3.

    Isotype

    IgG
  • Indications d'application

    WB 1:300-5000
    IHC-P 1:200-400

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 μg/μL

    Buffer

    Aqueous buffered solution containing 1xTBS ( pH 7.4), 1 % BSA, 40 %Glycerol and 0.05 % Sodium Azide.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    Store at -20°C for 12 months.

    Date de péremption

    12 months
  • Antigène

    ERBB3 (Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3))

    Autre désignation

    HER3/ErbB3

    Sujet

    Synonyms: c erbB 3 antibody, c erbB3 antibody, Erb b2 receptor tyrosine kinase 3 antibody, ErbB 3 antibody, ERBB3 antibody, ERBB3 protein antibody, erbB3 S antibody, ERBB3_HUMAN antibody, Glial growth factor receptor antibody, HER 3 antibody, HER3 antibody, Human epidermal growth factor receptor 3 antibody, LCCS2 antibody, MDA BF 1 antibody, MGC88033 antibody, p180 ErbB3 antibody, p45 sErbB3 antibody, p85 sErbB3 antibody, proto-oncogene-like protein c ErbB 3 antibody, proto-oncogene-like protein c ErbB3 antibody, Proto-oncogene-like protein c-ErbB-3 antibody, Receptor tyrosine protein kinase erbB 3 antibody, Receptor tyrosine protein kinase erbB3 antibody, Receptor tyrosine-protein kinase erbB-3 antibody, Tyrosine kinase type cell surface receptor HER3 antibody, Tyrosine kinase-type cell surface receptor HER3 antibody, v erb b2 avian erythroblastic leukemia viral oncogene homolog 3 antibody, v erb b2 erythroblastic leukemia viral oncogene homolog 3 (avian) antibody, v erb b2 erythroblastic leukemia viral oncogene homolog 3 antibody

    Background: The ErbB3 gene encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. ErbB3 is a membrane-bound protein which has a neuregulin binding domain but not an active kinase domain. It can therefore bind this ligand but cannot convey a signal into the cell via protein phosphorylation. However it does form heterodimers with other EGF receptor family members which do have kinase activity. Heterodimerization leads to the activation of pathways which lead to cell proliferation or differentiation. Amplification of this gene and/or overexpression of its protein have been reported in numerous cancers including prostate, bladder and breast tumors. Alternate transcriptional splice variants encoding different isoforms have been characterized. One isoform lacks the intermembrane region and is secreted outside the cell. This form acts to modulate the activity of the membrane-bound form. Additional splice variants have also been reported but they have not been thoroughly characterized.

    ID gène

    2065

    UniProt

    P21860

    Pathways

    Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway
Vous êtes ici:
Chat with us!